Showing results (71-80 of 151) with videos related to
Sort By:
Pageof 16
Cancers|December 23, 2023
The Role of Adjuvant Radiotherapy for the Treatment of Resected High-Risk Stage III Cutaneous Melanoma in the Era of Modern Systemic TherapiesSeth Kibel, Nathan Kuehne, Mauricio Fernando Ribeiro, et al.Science Immunology|December 16, 2018
Generation and molecular recognition of melanoma-associated antigen-specific human γδ T cellsPatricia M Benveniste, Sobhan Roy, Munehide Nakatsugawa, et al.Cell Reports. Medicine|March 7, 2025
Phase 1 study of IMCnyeso, a T cell receptor bispecific ImmTAC targeting NY-ESO-1-expressing malignanciesJuanita S Lopez, Mohammed Milhem, Marcus O Butler, et al.Cancers|September 9, 2023
Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer CentreErica C Koch Hein, Maysa Vilbert, Ian Hirsch, et al.Journal for Immunotherapy of Cancer|January 23, 2021
Biologic subtypes of melanoma predict survival benefit of combination anti-PD1+anti-CTLA4 immune checkpoint inhibitors versus anti-PD1 monotherapyApril A N Rose, Susan M Armstrong, David Hogg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2019
Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201)Jason J Luke, Daniel J Olson, Jacob B Allred, et al.Nature Communications|December 8, 2020
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanomaAntoni Ribas, Alain Algazi, Paolo A Ascierto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2022
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal MelanomaRichard D Carvajal, Paul Nathan, Joseph J Sacco, et al.JNCI Cancer Spectrum|April 28, 2020
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic IndexDaphne Day, Christina Guo, Yada Kanjanapan, et al.Cancers|June 2, 2021
Defining the Criteria for Reflex Testing for <i>BRAF</i> Mutations in Cutaneous Melanoma PatientsSarah Zhou, Daniel Sikorski, Honghao Xu, et al.Pageof 16